<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2959911-A1" country="EP" doc-number="2959911" kind="A1" date="20151230" family-id="49127210" file-reference-id="248648" date-produced="20180825" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="160452767" ucid="EP-2959911-A1"><document-id><country>EP</country><doc-number>2959911</doc-number><kind>A1</kind><date>20151230</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-14810943-A" is-representative="YES"><document-id mxw-id="PAPP193868502" load-source="patent-office" format="original"><country>EP</country><doc-number>14810943.2</doc-number><date>20140513</date><lang>ZH</lang></document-id><document-id mxw-id="PAPP193868503" load-source="docdb" format="epo"><country>EP</country><doc-number>14810943</doc-number><kind>A</kind><date>20140513</date><lang>ZH</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC162026312" ucid="CN-201310230521-A" load-source="docdb"><document-id format="epo"><country>CN</country><doc-number>201310230521</doc-number><kind>A</kind><date>20130612</date></document-id></priority-claim><priority-claim mxw-id="PPC162033679" ucid="CN-2014077352-W" load-source="docdb"><document-id format="epo"><country>CN</country><doc-number>2014077352</doc-number><kind>W</kind><date>20140513</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-1987765265" load-source="docdb">A61K  36/634       20060101AFI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987767002" load-source="docdb">A61K  36/233       20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987772549" load-source="docdb">A61K  47/14        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987774549" load-source="docdb">A61K  31/375       20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987784841" load-source="docdb">A61K  31/51        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987788604" load-source="docdb">A61P  11/00        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987793013" load-source="docdb">A61K  47/10        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987795336" load-source="docdb">A61P  31/00        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987795373" load-source="docdb">A61K  47/34        20060101ALI20151201BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1987797263" load-source="docdb">A61K   9/107       20060101ALI20151201BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1987765197" load-source="docdb" scheme="CPC">A61K  36/634       20130101 FI20150121BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987767158" load-source="docdb" scheme="CPC">A61K  31/51        20130101 LI20150121BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987793430" load-source="docdb" scheme="CPC">A61K  31/375       20130101 LI20150121BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987796517" load-source="docdb" scheme="CPC">A61K  36/233       20130101 LI20150313BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987797224" load-source="docdb" scheme="CPC">A61K  47/14        20130101 LI20150121BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987797306" load-source="docdb" scheme="CPC">A61K   9/1075      20130101 LI20150515BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT165549767" lang="DE" load-source="patent-office">VERBINDUNG ZUR HERSTELLUNG EINER FRUCTUS-FORSYTHIAE-RADIX-BUPLEURI-ÖLNANOEMULSION</invention-title><invention-title mxw-id="PT165549768" lang="EN" load-source="patent-office">COMPOUND FRUCTUS FORSYTHIAE-RADIX BUPLEURI OIL NANOEMULSION PREPARATION</invention-title><invention-title mxw-id="PT165549769" lang="FR" load-source="patent-office">PRÉPARATION D'UNE NANOÉMULSION D'UN COMPOSÉ D'HUILE DE FRUCTUS FORSYTHIAE-RADIX BUPLEURI</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR1103331737" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ZHANG XIAOYAN</last-name><address><country>CN</country></address></addressbook></applicant><applicant mxw-id="PPAR1103321039" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ZHANG, XIAOYAN</last-name></addressbook></applicant><applicant mxw-id="PPAR1101641651" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Zhang, Xiaoyan</last-name><iid>101499088</iid><address><street>No.302 Unit 1 Building 8 Yideyuan No.160 Jinbin Avenue Hedong District</street><city>Tianjin 300161</city><country>CN</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR1103303413" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ZHANG XIAOYAN</last-name><address><country>CN</country></address></addressbook></inventor><inventor mxw-id="PPAR1103318356" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ZHANG, XIAOYAN</last-name></addressbook></inventor><inventor mxw-id="PPAR1101641340" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>ZHANG, XIAOYAN</last-name><address><street>No.302 Unit 1 Building 8 Yideyuan No.160 Jinbin Avenue Hedong District</street><city>Tianjin 300161</city><country>CN</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR1101639700" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Walsh, Marie Goretti</last-name><suffix>et al</suffix><iid>101480979</iid><address><street>Hanna Moore + Curley 13 Lower Lad Lane</street><city>Dublin 2, D02 T668</city><country>IE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="CN-2014077352-W"><document-id><country>CN</country><doc-number>2014077352</doc-number><kind>W</kind><date>20140513</date><lang>ZH</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2014198173-A1"><document-id><country>WO</country><doc-number>2014198173</doc-number><kind>A1</kind><date>20141218</date><lang>ZH</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS660707445" load-source="docdb">AL</country><country mxw-id="DS660627917" load-source="docdb">AT</country><country mxw-id="DS660707451" load-source="docdb">BE</country><country mxw-id="DS660706340" load-source="docdb">BG</country><country mxw-id="DS660628489" load-source="docdb">CH</country><country mxw-id="DS660730415" load-source="docdb">CY</country><country mxw-id="DS660627918" load-source="docdb">CZ</country><country mxw-id="DS660707452" load-source="docdb">DE</country><country mxw-id="DS660730416" load-source="docdb">DK</country><country mxw-id="DS660730417" load-source="docdb">EE</country><country mxw-id="DS660789921" load-source="docdb">ES</country><country mxw-id="DS660706341" load-source="docdb">FI</country><country mxw-id="DS660706342" load-source="docdb">FR</country><country mxw-id="DS660707453" load-source="docdb">GB</country><country mxw-id="DS660730418" load-source="docdb">GR</country><country mxw-id="DS660707454" load-source="docdb">HR</country><country mxw-id="DS660627923" load-source="docdb">HU</country><country mxw-id="DS660628490" load-source="docdb">IE</country><country mxw-id="DS660730419" load-source="docdb">IS</country><country mxw-id="DS660706347" load-source="docdb">IT</country><country mxw-id="DS660730420" load-source="docdb">LI</country><country mxw-id="DS660713312" load-source="docdb">LT</country><country mxw-id="DS660628964" load-source="docdb">LU</country><country mxw-id="DS660713313" load-source="docdb">LV</country><country mxw-id="DS660713314" load-source="docdb">MC</country><country mxw-id="DS660628965" load-source="docdb">MK</country><country mxw-id="DS660628966" load-source="docdb">MT</country><country mxw-id="DS660627924" load-source="docdb">NL</country><country mxw-id="DS660789922" load-source="docdb">NO</country><country mxw-id="DS660628503" load-source="docdb">PL</country><country mxw-id="DS660713320" load-source="docdb">PT</country><country mxw-id="DS660627925" load-source="docdb">RO</country><country mxw-id="DS660713321" load-source="docdb">RS</country><country mxw-id="DS660628504" load-source="docdb">SE</country><country mxw-id="DS660706348" load-source="docdb">SI</country><country mxw-id="DS660789923" load-source="docdb">SK</country><country mxw-id="DS660628505" load-source="docdb">SM</country><country mxw-id="DS660628971" load-source="docdb">TR</country></ep-contracting-states><ep-extended-states><ep-extended-state-data><country>BA</country></ep-extended-state-data><ep-extended-state-data><country>ME</country></ep-extended-state-data></ep-extended-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA166480865" lang="EN" load-source="patent-office"><p id="pa01" num="0001">A compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, having droplet size between 10 nm and 100 nm, and prepared from raw materials with the following percentages by weight: 12.00%-28.00% of a surfactant, 15.00%-30.00% of a co-surfactant, 3.00%-8.00% of oil, 0.10%-5.00% of Forsythia suspensa oil, 0.10%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01%-0.05% of vitamin B<sub>1</sub> and 20.00%-68.40% of distilled water, and the total percentages by weight of all the raw materials is 100%.</p></abstract><abstract mxw-id="PA166760677" lang="EN" source="EPO" load-source="docdb"><p>A compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, having droplet size between 10 nm and 100 nm, and prepared from raw materials with the following percentages by weight: 12.00%-28.00% of a surfactant, 15.00%-30.00% of a co-surfactant, 3.00%-8.00% of oil, 0.10%-5.00% of Forsythia suspensa oil, 0.10%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01%-0.05% of vitamin B 1  and 20.00%-68.40% of distilled water, and the total percentages by weight of all the raw materials is 100%.</p></abstract><description mxw-id="PDES98405566" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b>Technical Field of the Invention</b></heading><p id="p0001" num="0001">The present invention, pertaining to the medical field, relates to a compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, and particularly relates to a transparent and stable compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation.</p><heading id="h0002"><b>Background of the Invention</b></heading><p id="p0002" num="0002">Forsythia suspensa is a Chinese medicine for clearing away heat and removing toxic substances with antibacterial, heart-tonifying, diuresis-promoting, and vomiting-stopping pharmacological effects, etc., it mainly treats early pyreticosis, anemopyretic cold, fever, vexation, laryngopharynx swelling and pain, and acute nephritis, etc. The main components of Forsythia suspensa volatile oil are B-pinene, A-pinene, etc. The Forsythia suspensa volatile oil has antibacterial and anti-virus effects, and has obvious effect for inhibiting staphylococcus aureus, diplococcus pneumoniae, and Candida albicans. The volatile essential oil (from yellowish-brown to brown) of Radix bupleuri oil has antipyretic, YANG-invigorating, and liver-soothing effects, which is used for treating fever due to common cold, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, and distending pain in the chest and hypochondrium. At present, the mixture of compound Forsythia<!-- EPO <DP n="2"> --> suspense oil and Radix bupleuri oil does not have a nanoemulsion preparation. The Forsythia suspense oil and Radix bupleuri oil have good curative efficacy with small toxic side effect, however, they are insoluble in water and they are volatile, and have low stability and low bioavailability, thus the therapeutic effect is affected. Vitamin C, also called L-ascorbic acid, is water-soluble vitamin. The vitamin C in food is absorbed by upper small intestine of human body. Normally, most vitamin C is decomposed in vivo into oxalic acid by metabolism or forms ascorbic acid-2-sulfuric acid by combining with sulfuric acid and is excreted in the urine; the other portion may directly be excreted in vitro in the urine. Vitamin B<sub>1</sub> is mainly for the prevention and treatment of vitamin B<sub>1</sub> deficiency, such as "beriberi", peripheral neuritis and dyspepsia. Supplement of vitamin B<sub>1</sub> is needed under the following circumstances: during pregnancy or lactation, hyperthyroidism, burns, long-term chronic infection, heavy physical labor, malabsorption syndrome accompanied by liver and gall diseases, disease of the small intestine system, and after gastrectomy.</p><heading id="h0003"><b>Summary of the Invention</b></heading><p id="p0003" num="0003">In view of the above problems and defects in the prior art, an object of the present invention is to provide a compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation which has uniform and accurate content, stable quality, and high bioavailability, and is easy to prepare.</p><p id="p0004" num="0004">The technical solution for realizing the above object is a compound<!-- EPO <DP n="3"> --> Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, comprising raw materials with the following percentages by weight:
<ul><li>12.00%-28.00% of a surfactant, 15.00%-30.00% of a co-surfactant, 3.00%-8.00% of oil, 0.10%-5.00% of Forsythia suspensa oil, 0.10%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01 %-0.05% of vitamin B<sub>1</sub> and 20.00%-68.40% of distilled water, and the total percentages by weight of all the raw materials is 100%.</li></ul></p><p id="p0005" num="0005">A preferred formulation of the compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation comprises raw materials with the following percentages by weight:
<ul><li>16.00%-28.00% of a surfactant, 16.00%-30.00% of a co-surfactant, oil 4.00%-8.00% of oil, 1.00%-5.00% of Forsythia suspensa oil, 1.00%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01%-0.05% of vitamin B<sub>1</sub> and 20.00%-60.00% of distilled water, and the total percentages by weight of all the raw materials is 100%.</li></ul></p><p id="p0006" num="0006">The best formulation of the compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation comprises raw materials with the following percentages by weight:
<ul><li>A compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, characterized in that, it is prepared from raw materials with the following percentages by weight: 24.00% of a surfactant phase, 30.00% of a co-surfactant, 7.00% of oil, 3.00% of Forsythia suspensa oil, 3.00% of Radix bupleuri oil, 0.01% of vitamin C, 0.01% of vitamin B<sub>1</sub> and 32.98% of distilled water, and the total percentages by weight of all<!-- EPO <DP n="4"> --></li><li>the raw materials is 100%.</li><li>The surfactant is Tween-80;</li><li>The co-surfactant is ethanol;</li><li>The oil is ethyl acetate.</li></ul></p><p id="p0007" num="0007">A nonionic surfactant with no toxin and good biocompatibility is selected by the present invention for the selection of surfactants. The nonionic surfactant is relatively stable in solution, is less susceptible to strong electrolyte or inorganic salts or acid-bases, and it has good compatibility with other surfactants, and hemolysis is small. Theoretically, HLB value of the surfactant needs to be between 8 and 18 for the preparation of O/W type nanoemulsion, but a liquid nonionic surfactant with HLB between 10 and 15 is selected by the invention in consideration of the simplicity of preparation process, i.e. easy formation of nanoemulsion and stability of the prepared nanoemulsion. The surfactant is Tween-80.</p><p id="p0008" num="0008">A co-surfactant with small irritation mainly including ethanol, is selected by the invention in order to adjust the hydrophilic-lipophilic balance (HLB) value of the surfactant, can further reduce interfacial tension, enhance flexibility and rigidity of membrane, insert the surfactant into the interfacial film, promote the formation of the membrane with very small curvature radius and enlarge the formation region of the nanoemulsion.</p><p id="p0009" num="0009">Ethyl acetate is selected as oil by the invention for use according to the principle of "when HLB of the surfactant needed by the emulsified oil phase is close to that of the surfactant phase, the resulting emulsion is<!-- EPO <DP n="5"> --> stable". The oil is liquid at room temperature.</p><p id="p0010" num="0010">Preparation method of the compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation of the present invention specifically comprises the following steps:
<ol><li>(1) preparation of the surfactant phase: weigh the surfactant according to the formulation ratio, and compound with the co-surfactant according to the ratio, calculate HLB value of the system and stir evenly and fully. HLB values of common emulsifiers can be found in some chemical manuals, such as "<nplcit id="ncit0001" npl-type="b"><text>Handbook of Chemical Products" published by the Chemical Industry Press</text></nplcit>. Since the hydrophile-lipophile balance (HLB) value of the surfactant is adductive, HLB value of the surfactant can be obtained by quality averaging method. For example, after mixing surfactant A and surfactant B, the HLB<sub>AB</sub> of the mixed surfactant is <maths id="math0001" num=""><math display="block"><mrow><msub><mi mathvariant="normal">HLB</mi><mi mathvariant="normal">AB</mi></msub><mo>=</mo><mfenced separators=""><msub><mi mathvariant="normal">W</mi><mi mathvariant="normal">A</mi></msub><mo>⁢</mo><msub><mi mathvariant="normal">HLB</mi><mi mathvariant="normal">A</mi></msub><mo>+</mo><msub><mi mathvariant="normal">W</mi><mi mathvariant="normal">B</mi></msub><mo>⁢</mo><msub><mi mathvariant="normal">HLB</mi><mi mathvariant="normal">B</mi></msub></mfenced><mo>/</mo><mfenced separators=""><msub><mi mathvariant="normal">W</mi><mi mathvariant="normal">A</mi></msub><mo>+</mo><msub><mi mathvariant="normal">W</mi><mi mathvariant="normal">B</mi></msub></mfenced></mrow></math><img id="ib0001" file="imgb0001.tif" wi="93" he="11" img-content="math" img-format="tif"/></maths><br/>
In formula
<ul><li>W<sub>A</sub>, W<sub>B</sub> - - weight of the surfactant A and the surfactant B of the mixture;</li><li>HLB<sub>A</sub>, HLB<sub>B</sub> - -HLB value of the surfactant A and the surfactant B.</li></ul></li><li>(2) preparation of oil phase: select oil according to the HLB value of the surfactant phase, adjust ratio of the oil to make the HLB value needed thereby to be close to that of the surfactant phase.</li><li>(3) change ratio of the surfactant phase and the oil phase according to the regularity of 9:1 to 1:9, add formulation ratio of Forsythia suspensa oil<!-- EPO <DP n="6"> --> therein, stir to fully dissolve it, slowly add distilled water at 20 DEG C to 25 DEG C and fully stir until forming a faint yellow O/W nanoemulsion which is clear and transparent, has a small viscosity and has liquidity.</li></ol></p><p id="p0011" num="0011">The invention has an appearance of faint yellow transparent liquid with excellent stability: durational stability refers to the extent to which the appearance of nanoemulsion varies with time when the nanoemulsion is stored under natural varying condition at room temperature. The durational stability is proved preferable as the Forsythia suspensa oil nanoemulsion preparation is durably transparent without finding turbidity or precipitate, which is an important criterion for evaluating nanoemulsion oral liquid. Place the Forsythia suspensa oil nanoemulsion oral liquid in a tube, seal, centrifuge at a rotating speed of 12000r/min for 20 minutes, the oral liquid is not delaminated and is still clear and transparent.</p><p id="p0012" num="0012">The compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation of the present invention has antipyretic, antibacterial and virus-inhibiting effects, and has obvious effect for inhibiting staphylococcus aureus, diplococcus pneumoniae, and Candida albicans. Clinically, it can be used for treating heat cold, upper respiratory tract infection, etc. Usage: take 50 ml three times a day for oral administration; apply externally below the eyes and nose; spray into the nose; spray in the air.</p><heading id="h0004"><b>Compared with the prior art, the compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation of the present<!-- EPO <DP n="7"> --> invention has the following advantages:</b></heading><p id="p0013" num="0013"><ol><li>1) The thermodynamic stability is high. Operation for the preparation is relatively simple, and there is no phase separation and no precipitation, and the storage stability is improved;</li><li>2) The transmittance is good, any heterogeneity or presence of precipitate is easy to be detected, and the sensory quality is improved;</li><li>3) The antiseptic performance is improved, because the dispersed phase fluid is smaller, which can prevent the invasion of bacteria and increase solubility of some active ingredients;</li><li>4) It has preferable solubilization, which can effectively improve the solubility of poorly water soluble drugs;</li><li>5) It can improve the solubility of Forsythia suspensa oil and Radix bupleuri oil, delay the recession time of Forsythia suspensa oil, thereby improving the bioavailability of Forsythia suspensa oil;</li><li>6) The process is simple and is suitable for large scale production.</li></ol></p><heading id="h0005"><b>Detailed Description of the Invention</b></heading><p id="p0014" num="0014">Preparation method of the compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation of the present invention will be further illustrated below with Examples given by the inventor.</p><heading id="h0006"><b>Example 1</b></heading><p id="p0015" num="0015">Accurately weigh 28.0 g of Tween-80, 28.0 g of ethanol and 8.0 g of<!-- EPO <DP n="8"> --> ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 0.1 g of Forsythia suspensa oil, 0.1 g of Radix bupleuri oil, 0.05 g of vitamin C and 0.05 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0007"><b>Example 2</b></heading><p id="p0016" num="0016">Accurately weigh 12.0 g of Tween-80, 15.0 g of ethanol and 3.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 1.0 g of Forsythia suspensa oil, 1.0 g of Radix bupleuri oil, 0.03 g of vitamin C and 0.03 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.1 g.<!-- EPO <DP n="9"> --></p><heading id="h0008"><b>Example 3</b></heading><p id="p0017" num="0017">Accurately weigh 16.0 g of Tween-80, 20.0 g of ethanol and 4.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 1.5 g of Forsythia suspensa oil, 1.5 g of Radix bupleuri oil, 0.02 g of vitamin C and 0.02 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0009"><b>Example 4</b></heading><p id="p0018" num="0018">Accurately weigh 25.0 g of Tween-80, 30.0 g of ethanol, and 5.1 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 2.0 g of Forsythia suspensa oil, 2.0 g of Radix bupleuri oil, 0.02 g of vitamin C and 0.02 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix<!-- EPO <DP n="10"> --> bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0010"><b>Example 5</b></heading><p id="p0019" num="0019">Accurately weigh 12.0 g of Tween-80, 16.0 g of ethanol, and 3.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 0.3 g of Forsythia suspensa oil, 0.3 g of Radix bupleuri oil, 0.02 g of vitamin C and 0.02 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0011"><b>Example 6</b></heading><p id="p0020" num="0020">Accurately weigh 12.0 g of Tween-80, 18.0 g of ethanol and 3.0 g of ethyl acetate, place the mixture into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 0.5 g of Forsythia suspensa oil, 0.5 g of Radix bupleuri oil, 0.01 g of vitamin C and 0.01 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while<!-- EPO <DP n="11"> --> stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the product, the total weight thereof is 100.0 g.</p><heading id="h0012"><b>Example 7</b></heading><p id="p0021" num="0021">Accurately weigh 24.0 g of Tween-80, 30.0 g of ethanol and 7.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 3.0 g of Forsythia suspensa oil, 3.0 g of Radix bupleuri oil, 0.01 g of vitamin C and 0.01 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0013"><b>Example 8</b></heading><p id="p0022" num="0022">Accurately weigh 24.0 g of Tween-80, 28.0 g of ethanol and 7.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 1.0 g of Forsythia suspensa oil, 5.0 g of Radix bupleuri oil, 0.01 g of vitamin C and 0.01 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually<!-- EPO <DP n="12"> --> varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p><heading id="h0014"><b>Example 9</b></heading><p id="p0023" num="0023">Accurately weigh 24.0 g of Tween-80, 28.0 g of ethanol and 7.0 g of ethyl acetate, place them into a beaker, manually stir to fully and homogeneously mix the liquid at room temperature of 20 DEG C, directly add 5.0 g of Forsythia suspensa oil, 1.0 g of Radix bupleuri oil, 0.01 g of vitamin C and 0.01 g of vitamin B<sub>1</sub>, stir thoroughly, and then slowly add distilled water while manually stirring, the system viscosity gradually varies from being small in the very beginning to large with the increasing of amount of the distilled water added, keep dropwise adding while stirring, when the system suddenly becomes thin, the product obtained at this time is the stable faint yellow transparent Forsythia suspensa-Radix bupleuri oil nanoemulsion oral liquid, weigh the liquid, the total weight thereof is 100.0 g.</p></description><claims mxw-id="PCLM90460531" lang="EN" load-source="patent-office"><!-- EPO <DP n="13"> --><claim id="c-en-0001" num="0001"><claim-text>A Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, <b>characterized in that</b>, it is prepared from raw materials with the following percentages by weight: 12.00%-28.00% of a surfactant, 15.00%-30.00% of a co-surfactant, 3.00%-8.00% of oil, 0.10%-5.00% of Forsythia suspensa oil, 0.10%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01%-0.05% of vitamin B<sub>1</sub> and 20.00%-68.40% of distilled water, the total percentages by weight of all the raw materials being 100%; the surfactant is Tween-80; the co-surfactant is ethanol; and the oil is ethyl acetate.</claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation of claim 1, <b>characterized in that</b>, it is prepared from raw materials with the following percentages by weight: 16.00%-28.00% of a surfactant, 16.00%-30.00% of a co-surfactant, 4.00%-8.00% of oil, 1.00%-5.00% of Forsythia suspensa oil, 1.00%-5.00% of Radix bupleuri oil, 0.01%-0.05% of vitamin C, 0.01%-0.05% of vitamin B<sub>1</sub> and 20.00%-60.00% of distilled water, the total percentages by weight of all the raw materials being 100%.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>A compound Forsythia suspensa-Radix bupleuri oil nanoemulsion preparation, <b>characterized in that</b>, it is prepared from raw materials with the following percentages by weight: 24.00% of a surfactant phase, 30.00% of a co-surfactant, 7.00% of oil, 3.00% of Forsythia suspensa oil, 3.00% of Radix bupleuri oil, 0.01% of vitamin C, 0.01% of vitamin B<sub>1</sub> and 32.98% of distilled water, the total percentages by weight of all the raw materials being 100%.</claim-text></claim></claims><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="161" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="165" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
